Jul 18, 2025 / 08:00AM GMT
Holger Lembrer - Boule Diagnostics AB - Chief Financial Officer
Good Morning everybody and welcome to the 2nd quarter's earnings call for Boor Diagnostics. I'm Jorge Lambe, CFO for Boo Diagnostics, and with me I have our CEO Torin Nielsen. After our presentation, we will open up for questions. Please also feel free to type questions in the chat field. With that, I'm handing over to you, Torman.
Torben Nielsen - Boule Diagnostics AB - Chief Executive Officer
Thank you, Volger and good morning and welcome to all of you joining this C2 earnings call.
Let's begin by looking at the highlights of the quarter.
The 2nd quarter of the year saw the continued effects of the geopolitical instability with longer than usual supply chain lead times.
Delayed payments from key customers due to continuing bank restrictions.
An unfavorable effects development from a weakening US dollar.
22 was overall and relatively speaking, a stable quarter.
With a 3.3% organic decline compared to last year.
Instrument unit
Q2 2025 Boule Diagnostics AB Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
